000 | 01742 a2200493 4500 | ||
---|---|---|---|
005 | 20250512023920.0 | ||
264 | 0 | _c19880725 | |
008 | 198807s 0 0 eng d | ||
022 | _a0002-9149 | ||
024 | 7 |
_a10.1016/0002-9149(88)91371-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLeier, C V | |
245 | 0 | 0 |
_aCardiovascular pharmacology of dopexamine in low output congestive heart failure. _h[electronic resource] |
260 |
_bThe American journal of cardiology _cJul 1988 |
||
300 |
_a94-9 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdrenergic Agonists _xadverse effects |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 |
_aCardiac Output _xdrug effects |
650 | 0 | 4 |
_aCardiac Output, Low _xcomplications |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aDopamine _xadverse effects |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHeart _xdrug effects |
650 | 0 | 4 |
_aHeart Failure _xcomplications |
650 | 0 | 4 |
_aHemodynamics _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKidney _xphysiopathology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aRenal Circulation _xdrug effects |
650 | 0 | 4 |
_aStroke Volume _xdrug effects |
650 | 0 | 4 |
_aVascular Resistance _xdrug effects |
700 | 1 | _aBinkley, P F | |
700 | 1 | _aCarpenter, J | |
700 | 1 | _aRandolph, P H | |
700 | 1 | _aUnverferth, D V | |
773 | 0 |
_tThe American journal of cardiology _gvol. 62 _gno. 1 _gp. 94-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0002-9149(88)91371-9 _zAvailable from publisher's website |
999 |
_c2904055 _d2904055 |